WO2016174210A1 - An annuloplasty system and a method for monitoring the effectiveness of an annuloplasty treatment - Google Patents

An annuloplasty system and a method for monitoring the effectiveness of an annuloplasty treatment Download PDF

Info

Publication number
WO2016174210A1
WO2016174210A1 PCT/EP2016/059623 EP2016059623W WO2016174210A1 WO 2016174210 A1 WO2016174210 A1 WO 2016174210A1 EP 2016059623 W EP2016059623 W EP 2016059623W WO 2016174210 A1 WO2016174210 A1 WO 2016174210A1
Authority
WO
WIPO (PCT)
Prior art keywords
sensor
regurgitation
annuloplasty
ring assembly
annuloplasty ring
Prior art date
Application number
PCT/EP2016/059623
Other languages
French (fr)
Inventor
Daniel Hayoz
Enrico FERMI
Daniele Zanotti
Original Assignee
Kephalios S.A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53015669&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2016174210(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kephalios S.A.S. filed Critical Kephalios S.A.S.
Priority to EP16719099.0A priority Critical patent/EP3288494B1/en
Priority to US15/569,813 priority patent/US11147670B2/en
Publication of WO2016174210A1 publication Critical patent/WO2016174210A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2445Annuloplasty rings in direct contact with the valve annulus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/029Measuring or recording blood output from the heart, e.g. minute volume
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/686Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/06Measuring blood flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/12Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48Diagnostic techniques
    • A61B8/488Diagnostic techniques involving Doppler signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2466Delivery devices therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0265Measuring blood flow using electromagnetic means, e.g. electromagnetic flowmeter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0285Measuring or recording phase velocity of blood waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0001Means for transferring electromagnetic energy to implants
    • A61F2250/0002Means for transferring electromagnetic energy to implants for data transfer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable

Definitions

  • the present invention relates to an annuloplasty system and a method for monitoring the effectiveness of an annuloplasty treatment .
  • Annuloplasty e.g. mitral or tricuspid annuloplasty
  • an annuloplasty device e.g. mitral ring or tri- cuspid ring
  • the surgeon sizes the valve annulus and choos ⁇ es an annuloplasty device accordingly. This procedure is per ⁇ formed on the arrested heart with a cardiopulmonary bypass. How- ever, the effectiveness of an implanted annuloplasty device can ⁇ not be assessed during the procedure, because the heart is ar ⁇ rested. Only upon restarting the heart is it possible to assess whether the device has had the desired effect to correct valve function .
  • annuloplasty devices such as in EP 2 468 215 Al or in WO 2006/012013 A2 have been developed. These annuloplas ⁇ ty devices can be reshaped in vivo which allows a further defor- mation of the annulus without having to replace the annuloplasty ring. The adjustment of such an annuloplasty ring replaces the second operation and hence reduces the damages from the second operation . However, the assessment whether the second operation was suc ⁇ cessful is only possible after a manipulation is completed.
  • transthoracic echocardiogram This assessment of the function of a heart valve is classically conducted with a transthoracic echocardiogram.
  • the transthoracic echocardiogram is conducted at a distance from the heart valve which limits the resolution of the echocardiogram.
  • the object of the present invention is to overcome the disad ⁇ vantages of the prior art and in particular to provide an annu ⁇ loplasty system which allows to assess the effect of a manipula ⁇ tion of an annuloplasty ring assembly when implanted.
  • the invention relates to an annu ⁇ loplasty system comprising a sensor that can measure a regurgitation of a valve.
  • annuloplasty system comprising an annuloplasty ring assembly, at least one sensor and an external monitor or a prompting device.
  • the annuloplasty ring assembly has an interface adapted to establish an operative connection with a manipulator.
  • the manipulator is utilized for manipulating said annuloplasty ring assembly.
  • the sensor is configured to de ⁇ tect regurgitation.
  • the external monitor or the prompting device is adapted to provide, e.g. display, information based on said detected regurgitation.
  • annuloplasty ring assembly is intended to cover devices utilized to reshape a valve.
  • the an- nuloplasty ring assembly is used to reshape a cardiac valve such as the mitral or tricuspid valve.
  • the annuloplasty ring assembly may comprise a tubular ring. This tubular ring is preferably an ⁇ chored in or sutured to a native heart valve.
  • manipula- tions of the shape and/or size of the annuloplasty ring assem ⁇ bly.
  • ring as used herein is intended to cover any shape for circumscribing at least a majority of a periphery of a valve annulus .
  • a ring may be closed (e.g. generally “0" shaped or gen ⁇ erally “D” shaped) or a ring may be open (e.g. generally “C” shaped) .
  • a ring does cover non round geometries (e.g. “D” shapes, elongated “C” shapes”) as well as round geometries (e.g. generally “0” shaped or generally “C” shaped) .
  • a ring may be in a non-planar 3D shape, e.g. generally a saddle shape.
  • the ring may be three dimensionally bent "0", "C” or "D” shaped.
  • the interface adapted to establish an operative connection is preferably adapted to establish a mechanical connection.
  • the me ⁇ chanical connection is utilized to deform the annuloplasty ring system with the manipulator.
  • the manipulation is utilized to alter the shape and/or size of a specific section of the annuloplasty ring assembly. Ideally this manipulation then influences the coaptation of leaflets of the valve and thus the regurgitation.
  • Exemplary interfaces suitable for the mechanical manipulation are shown in PCT/EP2013/072378 and
  • the interface is adapted to establish an operative connection where the manipulator transfers heat or electromag ⁇ netic waves or magnetic fields or other waves, e.g. ultrasound waves.
  • the manipulator transfers heat or electromag ⁇ netic waves or magnetic fields or other waves, e.g. ultrasound waves.
  • One embodiment of a manipulation with magnetic fields is shown in US 6,406,493 Bl .
  • Regurgitation refers to a blood flow going through the valve against an intended general direction. This flow leaks through the valve when the valve is closed.
  • mitral regurgi- tation is a flow in a heart from a left ventricle through a mi ⁇ tral valve to a left atrium.
  • the sensor is configured to detect regurgitation.
  • Regurgitation may be detected by the sensor by measuring a physical parameter generated by the regurgitation or by measuring a parameter, which is modified by the regurgitation. This parameter may be generated by the annuloplasty system or by an external source.
  • the sensor preferably measures speed and direction of the regur- gitation. Alternatively the sensor measures other physical quan ⁇ tities related to regurgitation such as pressure or sound.
  • the external monitor or prompting device is adapted to provide information based on the detected regurgitation.
  • the external monitor may be connected or connectable with a wire or wireless- ly to the sensor.
  • the senor In case of a wire connection, the sensor might be connected to the monitor over the wire, i.e. a transmission line preferably connecting the monitor to a connector of the annuloplasty ring and connecting means connecting the sensor to the connector and hence the transmission line. Additionally the external monitor or the prompting device may compare the regurgitation of the valve before and after a manip ⁇ ulation of the annuloplasty ring assembly and may inform a user of the annuloplasty device, e.g. a surgeon, based on the differ ⁇ ences .
  • a user of the annuloplasty device e.g. a surgeon
  • a user who manipulates the annuloplasty ring assembly, can mon ⁇ itor the impact of his manipulation on the external monitor. Thereby direct feedback on the effectiveness of his treatment is provided. This allows an optimal reshaping of the annuloplasty ring assembly and thus an improved patient outcome. Furthermore the evaluation of the effectiveness becomes easier and faster during the adjustment procedure.
  • the sensor comprises a Doppler-effect sensor to measure the regurgitation of the heart valve.
  • the Doppler-effeet allows a non-contact measurement of the regurgitation.
  • the Doppler-effeet can be utilized to measure flow velocities at a distance from the sensor.
  • the sensor comprises an ultrasound transducer.
  • the ultrasound transducer can generate ultrasound waves as well as detect an ultrasonic echo.
  • the ultrasound transducer preferably measures the regurgitation with the Doppler-effect .
  • the ultra- sound transducer generates an ultrasound beam or pulse.
  • the beam or pulse interacts with the regurgitation and is reflected to the ultrasound transducer, where the pulse or beam is detected.
  • an ultrasonic transmission measurement which uses transit times of the ultrasound waves to calculate an average flow velocity, can be utilized.
  • the senor may comprise a magnetic flow meter.
  • the magnetic flow meter such as a Hall effect sensor measures the regurgitation with a potential across a cross-section of the valve.
  • a magnetic field e.g. an alternating magnetic field, may be generated electromagnetically by the annuloplasty system.
  • the magnetic fields may be generated by a solenoid part of the annu ⁇ loplasty ring or part of the catheter.
  • the solenoid is part of the annuloplasty ring, the sole ⁇ noid may be wound around the ring or is arranged in the annulo ⁇ plasty ring.
  • An electric current is applied to the solenoid through the connector. This AC or DC current induces an oscil ⁇ lating or constant magnetic field.
  • Regurgitated blood acts as moving electrical conductor and interacts with the magnetic field.
  • an electromotive force is generated which may be detected with electrodes.
  • the electrodes send a signal contain ⁇ ing information on the regurgitation to the connector and to the monitor .
  • the solenoid may be wound around the catheter having a kind of C-shaped tip to have the solenoid partly around the annulus .
  • the solenoid is arranged in the catheter in a C-form in a C-shaped tip .
  • the magnetic field may be generated with permanent magnets comprised by the annuloplasty system, i.e. the annulo- plasty ring or the catheter.
  • the magnetic field is applied basi ⁇ cally perpendicular to the blood flow.
  • the blood flow acts as a moving electrical conductor, which in- teracts with the magnetic field.
  • an electromotive force is induced.
  • the induced electromotive force is related to the regurgitation. Said electromotive force is measured across a direction essentially perpendicular to the flow direction of the blood and essentially perpendicular to the magnetic field.
  • the change of the signal generated by the sole ⁇ noid and the regurgitation may be measured with any of the elec ⁇ trical parameters (tension, current or resistance) .
  • Another in ⁇ direct alternative may be a measurement of the variations of the magnetic field.
  • said sensor comprises a light conductor, e.g. an optical fiber.
  • the light conductor guides light, e.g. monochro ⁇ matic light, to the place where regurgitation is expected. The light interacts with the regurgitation and is reflected or scat ⁇ tered back to the light conductor/sensor.
  • a sec ⁇ ond light conductor is utilized to detect the scattering.
  • the light is reflected or scattered back in a specific way if regurgitation is present.
  • the sensor On the basis of this reflected or scattered back light, the sensor is able to detect if regurgita ⁇ tion is present.
  • a detection of the regurgitation with light offers a fast measurement of the regurgitation.
  • the light conductor may allow a space saving design of the sensor.
  • a micro camera might be applied on the ring or a catheter.
  • a fibre could be used for imaging using a camera outside of the body.
  • the senor comprises means to measure a spatial dis ⁇ tribution of a flow velocity.
  • the spatial resolution is measured by a ID phased array of ultrasound transducers and/or by sweeping the ultrasound transducer through a series of positions. The spatial resolution allows a localization of the "leaks" in the valve.
  • the manipulation procedure of the annuloplasty ring assembly can be adapted to reshape the mitral valve accordingly.
  • reshaping of the annuloplasty ring assembly in distinct places that are determined with the spatial distribu ⁇ tion the flow velocities is advantageous.
  • the sensor is connected to or connectable to or is part of the annuloplasty ring assembly.
  • the sensor is preferably situated at a location suited for measuring the regurgitation.
  • the sensor may be permanently connected to the annuloplasty ring assembly. A permanent connection would allow a long term moni- toring of the functioning of the valve.
  • the senor may be introduced after an implantation of the annuloplasty ring assembly for use during manipulation and/or removed after a manipulation procedure of the ring assem- bly.
  • the annuloplasty system comprises a delivery device connected or connectable to said interface, wherein the delivery device is adapted to deliver said manipulator.
  • the delivery device e.g. a catheter, is preferably adapted to enter the annuloplasty assembly.
  • the cathe ⁇ ter is connectable to the interface where the interface is ma ⁇ nipulated with heat or mechanical pressure or electrically or magnetically .
  • a "catheter” as used herein is intended refer to any flexible tubular structure suitable for medical applications adapted to provide a physical connection between the outside of the pa ⁇ tient's body and the annuloplasty ring assembly.
  • Alternative delivery devices may include but are not limited to tweezers or guide wires.
  • the delivery device is preferably removable and preferably adapted to reshape the annuloplasty assembly. This allows a sim ⁇ ple and versatile annuloplasty ring assembly.
  • the delivery device has a signal connector, which can connect said sensor to the external monitor.
  • the connector Through the connector the information read out by the sensor becomes availa ⁇ ble to the external monitor.
  • the connector may connect to the monitor with a wire or wirelessly.
  • the system comprises a mechanical connector, prefer- ably on a common unit with the signal connector.
  • a mechanical connector establishes a connection between the manipulator and the user.
  • the delivery device is preferably introduced through the mechanical connector.
  • the connector can be utilized to actuate the de ⁇ livery device, which may be comprised within the mechanical con ⁇ nector .
  • the delivery device includes the sensor.
  • the sensor may be placed flexibly and repositioned if advantageous because the delivery device can be positioned as desired.
  • An ad ⁇ ditional advantage is that the delivery device comprises the tools to manipulate the annuloplasty as well as the tools to as ⁇ sess the success of the manipulation in one device.
  • the delivery device as well as the annuloplasty ring assembly each includes at least one sensor.
  • at least one sensor could act as a sender and at least one sen ⁇ sor could act as a receiver.
  • the manipulator includes the sensor.
  • the manipulator comprises an inflatable balloon.
  • Preferred embodiments of the manipulator and delivery device comprising the inflatable balloon and the sensor are described in US 2014/0180126 Al, which is incorporated herein by refer ⁇ ence.
  • Inflatable balloons comprised by a catheter are simple and versatile manipulators.
  • the sensor may be placed directly on the balloon.
  • the sensor may be positioned on a tip of a balloon or on the connecting line used to inflate the balloon.
  • the tip of the bal- loon may be separate part, comprised by the connecting line or may be part of the balloon.
  • a placement of the sensor on the tip or the catheter has the advantage that it does not expose the sensor to the expansion of the balloon.
  • the annuloplasty system comprises a closed loop con ⁇ trol system adapted to monitor the change in regurgitation and adapted to manipulate the adjustable ring in dependence of the monitored changes. In the closed loop control system the regur- gitation is measured and compared to a threshold.
  • the control system controls the manipulator.
  • the manipulator manipulates the annuloplasty ring assembly such that a difference between the measured regurgitation and the threshold is minimal.
  • the control system automatically manipulates the assembly and thus a user interaction is minimal.
  • the invention further relates to a method of monitoring the ef ⁇ fectiveness of an annuloplasty treatment.
  • an annu ⁇ loplasty system is provided.
  • the annuloplasty system comprises an annuloplasty ring assembly, at least one sensor and an exter ⁇ nal monitor or prompting device.
  • the sensor is configured to de ⁇ tect regurgitation.
  • the external monitor or the prompting device is configured to display information based on the regurgitation detected by the sensor.
  • the annuloplasty ring assembly is manip- ulated with the manipulator.
  • the regurgitation is detected with said sensor and information based on said detected regurgitation with said monitor or prompting device is provided. If said de ⁇ tected regurgitation is above a threshold the adjustment is re ⁇ peated. If regurgitation is below the threshold the manipulation is stopped. Therewith the manipulation is directly controlled and only performed in an adequate quantity.
  • Fig. 1 is a schematic view of a mitral valve with regurgita ⁇ tion and an annuloplasty ring assembly
  • Fig. 2 is a schematic view of a first embodiment of an annulo plasty system according to the invention
  • Fig. 3 is a schematic view of a second embodiment of an annu- loplasty system according to the invention.
  • Fig. 4 is a schematic view of a third embodiment of an annulo plasty system according to the invention.
  • Fig. 5 is a schematic view of a fourth embodiment of an annu- loplasty system according to the invention.
  • Fig. 6 is a schematic view of a connector according to the in vention
  • Fig. 7 is a schematic representation of an output of an exter nal monitor.
  • FIG. 1 shows a cross-section schematic view of a mitral valve 14 with regurgitation 13 and an annuloplasty ring assembly 2.
  • the annuloplasty ring assembly 2 is used to manipulate the mi ⁇ tral valve 14.
  • the mitral valve 14 regulates a blood flow from an atrium 17 to a ventricle 18. Thereby a functioning mitral valve 14 allows only a flow from the atrium 17 to the ventricle
  • the mitral valve 14 closes.
  • the mitral valve 14 closes with an anterior leaflet 19 and a poste ⁇ rior leaflet 20.
  • the leaflets 19, 20 coapt and therewith prohib ⁇ it a flow from the ventricle 18 to the atrium 17.
  • the leaflets 19, 20 are held by tendinous chords 15, which hold the leaflets on the ventricular side. Certain medical conditions cause the leaflets 19, 20 to coapt insufficiently causing a regurgitation 13.
  • the regurgitation 13 is a back flow of blood from the ventricle 18 through the mitral valve.
  • the annuloplasty ring assembly 2 reshapes the mitral valve 14. Thereby, the coaptation of the leaflets 19, 20 is improved the regurgitation 13 reduced or stopped.
  • Figure 2 shows a schematic view of a first embodiment of an an- nuloplasty system 1.
  • a sensor 8 is part of an annuloplasty ring assembly 2.
  • the sensor 8 is connected with the external monitor 5 via connection means 21, a connector 12 and the transmission line 27.
  • the annuloplasty ring assembly 2 is arranged as an annular ring with an oval shape which is formed by a tube 9 with a "D" shaped or circular cross section.
  • the tube 9 is made out of Nitinol.
  • An outer wall 23 of the tube 9 is thicker than an inner wall 22 of the tube 9. Through this increased thickness of the outer wall 23 compared to the inner wall 22, the outer wall 23 is more rigid than the inner wall 22. Thereby the inner wall forms an inter ⁇ face through which the annuloplasty ring assembly may be manipu ⁇ lated.
  • PCT/EP2013/072378 and PCT/EP2015/051782 are suitable.
  • the sensor 8 comprises an ultrasound transducer and measures the regurgitation 13 of the mitral valve 14.
  • the ultrasound trans- ducer sends a pulse in the direction of the back flow.
  • the back flow modifies the pulse.
  • a reflection 11, which compromises information related to the regurgitation, is sent back to the sensor 8 via a transmission line 27.
  • the transmission line 27 may transmit particularly optical signals, electrical signals and/or pressure.
  • the sensor 8 detects the reflection and deduces the information related to the regurgitation.
  • a signal of the sensor 8 is transmitted to the connector 12 over connecting means 21. From the connector 12 the signal is sent with the transmission line 27 to the external monitor 5.
  • the external monitor 5 displays the regurgita- tion 13 to a user.
  • a catheter 7 is introduced into the tube 9 through the connector 12.
  • the catheter is then arranged between the outer wall 23 and the inner wall 22.
  • the catheter 7 comprises an inflatable bal- loon 4.
  • the balloon 4 is moveable around the circumference of the tube 9 (indicated with an arrow) .
  • the balloon 4 is expandable with gas or a liquid.
  • the gas or liquid is provided by an actuator 20 over a connecting line 26.
  • the balloon 4 When inflated with gas, the balloon 4 expands and displaces the inner wall 22 inwardly towards an inside area 25 of the tube 9.
  • the mitral valve 14, to which the assembly 2 is applied is adjusted. Due to the plastic deformation of the tube, the inwardly displaced wall re- mains in its expanded position.
  • this manipulation of the assembly 2 causes a change in the coaptation 16 of the mitral valve leaflets 19, 20 (see Fig.l) and consequently a change in regurgitation.
  • a new regurgitation 13' see Fig.
  • Figure 3 shows a schematic view of a second embodiment of the adjustable annuloplasty system 1.
  • the sensor 8 is comprised by the catheter 7.
  • the catheter 7 is introduced into the tube 9 through a connector 12 and moveable around the circumference of the annuloplasty ring assembly 2 (indicated with an arrow) .
  • the sensor 8 comprises an optical fi ⁇ ber and measures the regurgitation 13 of the mitral valve 14.
  • the optical fiber emits the optical signal at an end of the op ⁇ tical fiber, in the direction of the back flow.
  • the optical sig ⁇ nal is reflected by the blood, e.g. red blood cells.
  • the sensor 8 detects the reflection and deduces the information related to the regurgitation.
  • a signal of the sensor 8 is transmitted with the transmission line 27 to the external monitor 5.
  • the external monitor 5 may process signal further.
  • the external monitor 5 displays the regurgitation 13 to a user. The user can then choose to manipulate the annuloplasty ring assembly with a bal ⁇ loon 4 (see Fig . 1 ) .
  • the annuloplasty ring assembly is adjustable with a different mechanism in this embodiment.
  • Three actuation elements 10a, b, c are arranged in the tube 9 between the inner wall 22 and the outer wall 23.
  • Two actuation elements 10a, b are arranged at lateral portions of the tube 9, one actuation element 10c is ar ⁇ ranged at a posterior portion of the tube 2.
  • the three actuation elements 10 each comprise a stent.
  • the stents have a section in- tegrally formed with the outer wall 23.
  • the stents are expanda ⁇ ble with a balloon 4 (see Fig. 2) .
  • the three stents may be ex ⁇ panded with the same balloon or with a separate balloon each.
  • the balloon is inflated via the connecting line 26 (see Fig. 2) .
  • the stents expand inwardly because of the part integrally formed with the outer wall 23 is more rigid than the rest of the stent.
  • the stents therefore displace the inner wall 22 inwardly and ad ⁇ just the mitral valve leaflets 19, 20.
  • the adjustment mechanism of the assembly 2 can be utilized independent of the positioning of the sensor 8.
  • the actuation elements lOa-c in figure 3 may be utilized in the embodiments shown in figure 2 and 4.
  • FIG 4 shows a schematic view of a third embodiment of an an ⁇ nuloplasty system 1.
  • the sensor 8 is com- prised by the balloon 4.
  • the sensor 8 comprises an ultrasound transducer and measures the regurgitation 13 of the mitral valve 14.
  • the ultrasound transducer sends a pulse in the direction of the back flow.
  • the back flow modifies the pulse.
  • a reflection 11, which compromises information related to the regurgitation, is sent back to the sensor 8.
  • the sensor 8 detects the reflec ⁇ tion and deduces the information related to the regurgitation.
  • a signal of the sensor 8 is transmitted with the transmission line 27 to the external monitor 5.
  • the external monitor 5 may process signal further.
  • the external monitor 5 displays the regur- gitation 13 to a user.
  • the user can modify the annuloplasty ring assembly 2 directly thereafter with the balloon 4.
  • any kind of sensor as disclosed herein might be part of any element of the annuloplasty system as described herein.
  • the balloon might e.g. comprise an optical sensor or the catheter an ultrasound transducer etc.
  • FIG. 5 shows a schematic view of a fourth embodiment of an an- nuloplasty system according to the invention.
  • a solenoid 39 is wound around the tube 9.
  • the tube according to Figure 5 is an open ring such.
  • An electric current is applied to the solenoid 39 through connector 12.
  • This AC or DC current in ⁇ symbolizes an oscillating or constant magnetic field 40.
  • a regurgita- tion 13 e.g. a regurgitation of blood, acts as moving electrical conductor and interacts with the magnetic field 40.
  • an electromotive force is generated which may be detected with electrodes 38.
  • the electrodes 38 send a signal containing infor ⁇ mation on the regurgitation 13 to the connector 12.
  • FIG. 6 shows a schematic view of the connector 12.
  • the con ⁇ nector comprises two parts: a signal connector 36 and a mechani ⁇ cal connector 37.
  • the signal connector 36 is connected to the sensor with a sensor connection port 29 and to the external mon- itor with a monitor connection port 30.
  • the mechanical connector 37 establishes an operative connection between an actuator connection port 28 and a manipulator connection port 38. Both connection ports 38 and 29 may be connectable or connected or part of to the connecting line 26.
  • Figure 7 shows a schematic representation of an output of an ex ⁇ ternal monitor 5.
  • the external monitor 5 displays a flow veloci ⁇ ty on the y axis 32 and a time on the x-axis 31.
  • the flow veloc ⁇ ity may be measured at a particular location or an average ve- locity over the cross-section of the valve.
  • the flow velocity at the position of the regurgitation is displayed.
  • a positive flow 33 represents the blood flowing in the intended direction.
  • a negative flow represents the regurgitation 13.
  • An integration over the negative flow may indicate the volume 34 of blood that flows back. The user would identify the regurgitation 13 on the monitor. Then the user would manipulate the annulo- plasty ring assembly 2 (see fig. 2) .
  • the manipulation would improve the coaptation 16 (see fig. 2) and thus the regur ⁇ gitation 13 and the volume 34 would decrease.
  • the user would continue to manipulate until the regurgitation 34 drops below a threshold 35.
  • a threshold for the volume could be displayed.

Abstract

An annuloplasty system is provided, which comprises an annuloplasty ring assembly (2), at least one sensor (8) and an external monitor (5) or a prompting device. The annuloplasty ring assembly (2) has an interface adapted to establish an operative connection with a manipulator. The manipulator is utilized for manipulating said annuloplasty ring assembly (2). The sensor (8) is configured to detect regurgitation (13, 34). The external monitor (5) or the prompting device is adapted to provide, e.g. display, information based on said detected regurgitation (13, 34).

Description

An annuloplasty system and a method for monitoring the effectiveness of an annuloplasty treatment
The present invention relates to an annuloplasty system and a method for monitoring the effectiveness of an annuloplasty treatment .
Annuloplasty (e.g. mitral or tricuspid annuloplasty) is the im¬ plantation of an annuloplasty device (e.g. mitral ring or tri- cuspid ring) to deform and/or reinforce the valve annulus to correct insufficient valve function. During a classical annulo¬ plasty procedure, the surgeon sizes the valve annulus and choos¬ es an annuloplasty device accordingly. This procedure is per¬ formed on the arrested heart with a cardiopulmonary bypass. How- ever, the effectiveness of an implanted annuloplasty device can¬ not be assessed during the procedure, because the heart is ar¬ rested. Only upon restarting the heart is it possible to assess whether the device has had the desired effect to correct valve function .
If the repair has not been successful, the patient has to under¬ go a second operation. Without the second operation, there re¬ main certain possible long term consequences of a certain level of residual regurgitation. This procedure may improve the out- come of the implantation procedure.
Recently adjustable annuloplasty devices such as in EP 2 468 215 Al or in WO 2006/012013 A2 have been developed. These annuloplas¬ ty devices can be reshaped in vivo which allows a further defor- mation of the annulus without having to replace the annuloplasty ring. The adjustment of such an annuloplasty ring replaces the second operation and hence reduces the damages from the second operation . However, the assessment whether the second operation was suc¬ cessful is only possible after a manipulation is completed.
This assessment of the function of a heart valve is classically conducted with a transthoracic echocardiogram. The transthoracic echocardiogram is conducted at a distance from the heart valve which limits the resolution of the echocardiogram.
Equipping annuloplasty rings with sensors has been proposed. By way of example, US 2013/0006352 Al, proposes attaching a sensor capable of measuring pressure, temperature or blood velocity to a annuloplasty device. This sensor is a microelectromechanical system (MEMS) and may assist during the implantation procedure or in the years after it. Further during the implantation proce- dure the utilization of a positioning (xyz) sensor is particularly suggested. This xyz sensor allows an accurate positioning of the annuloplasty device by using an external system that reads the information transmitted from the sensor. However, the annuloplasty device according to US 2013/0006352 Al is not adjustable. Thus the information gathered by the sensor can only be utilized to assess whether an explantation is necessary . The object of the present invention is to overcome the disad¬ vantages of the prior art and in particular to provide an annu¬ loplasty system which allows to assess the effect of a manipula¬ tion of an annuloplasty ring assembly when implanted. In some non-limiting examples, the invention relates to an annu¬ loplasty system comprising a sensor that can measure a regurgitation of a valve. Some non-limiting examples focus on treating atrioventricular cardiac valves such as the mitral valve or the tricuspid valve, but the concept, function and benefit are not limited to these valves.
According to the invention the problem is solved with a system and a method according to the independent claims and their char¬ acterizing features.
It is suggested to provide an annuloplasty system comprising an annuloplasty ring assembly, at least one sensor and an external monitor or a prompting device. The annuloplasty ring assembly has an interface adapted to establish an operative connection with a manipulator. The manipulator is utilized for manipulating said annuloplasty ring assembly. The sensor is configured to de¬ tect regurgitation. The external monitor or the prompting device is adapted to provide, e.g. display, information based on said detected regurgitation.
As herein used the term "annuloplasty ring assembly" is intended to cover devices utilized to reshape a valve. Preferably the an- nuloplasty ring assembly is used to reshape a cardiac valve such as the mitral or tricuspid valve. The annuloplasty ring assembly may comprise a tubular ring. This tubular ring is preferably an¬ chored in or sutured to a native heart valve.
The term "manipulation" as used herein is limited to manipula- tions of the shape and/or size of the annuloplasty ring assem¬ bly.
The term "ring" as used herein is intended to cover any shape for circumscribing at least a majority of a periphery of a valve annulus . A ring may be closed (e.g. generally "0" shaped or gen¬ erally "D" shaped) or a ring may be open (e.g. generally "C" shaped) . A ring does cover non round geometries (e.g. "D" shapes, elongated "C" shapes") as well as round geometries (e.g. generally "0" shaped or generally "C" shaped) . A ring may be in a non-planar 3D shape, e.g. generally a saddle shape. The ring may be three dimensionally bent "0", "C" or "D" shaped. The interface adapted to establish an operative connection is preferably adapted to establish a mechanical connection. The me¬ chanical connection is utilized to deform the annuloplasty ring system with the manipulator. Preferably the manipulation is utilized to alter the shape and/or size of a specific section of the annuloplasty ring assembly. Ideally this manipulation then influences the coaptation of leaflets of the valve and thus the regurgitation. Exemplary interfaces suitable for the mechanical manipulation are shown in PCT/EP2013/072378 and
PCT/EP2015/051782.
Alternatively the interface is adapted to establish an operative connection where the manipulator transfers heat or electromag¬ netic waves or magnetic fields or other waves, e.g. ultrasound waves. One embodiment of a manipulation with magnetic fields is shown in US 6,406,493 Bl .
Regurgitation refers to a blood flow going through the valve against an intended general direction. This flow leaks through the valve when the valve is closed. For example mitral regurgi- tation is a flow in a heart from a left ventricle through a mi¬ tral valve to a left atrium.
The sensor is configured to detect regurgitation. Regurgitation may be detected by the sensor by measuring a physical parameter generated by the regurgitation or by measuring a parameter, which is modified by the regurgitation. This parameter may be generated by the annuloplasty system or by an external source. The sensor preferably measures speed and direction of the regur- gitation. Alternatively the sensor measures other physical quan¬ tities related to regurgitation such as pressure or sound.
The external monitor or prompting device is adapted to provide information based on the detected regurgitation. The external monitor may be connected or connectable with a wire or wireless- ly to the sensor.
In case of a wire connection, the sensor might be connected to the monitor over the wire, i.e. a transmission line preferably connecting the monitor to a connector of the annuloplasty ring and connecting means connecting the sensor to the connector and hence the transmission line. Additionally the external monitor or the prompting device may compare the regurgitation of the valve before and after a manip¬ ulation of the annuloplasty ring assembly and may inform a user of the annuloplasty device, e.g. a surgeon, based on the differ¬ ences .
A user, who manipulates the annuloplasty ring assembly, can mon¬ itor the impact of his manipulation on the external monitor. Thereby direct feedback on the effectiveness of his treatment is provided. This allows an optimal reshaping of the annuloplasty ring assembly and thus an improved patient outcome. Furthermore the evaluation of the effectiveness becomes easier and faster during the adjustment procedure.
Preferably, the sensor comprises a Doppler-effect sensor to measure the regurgitation of the heart valve. The Doppler-effeet allows a non-contact measurement of the regurgitation. Further, the Doppler-effeet can be utilized to measure flow velocities at a distance from the sensor. Preferably, the sensor comprises an ultrasound transducer. The ultrasound transducer can generate ultrasound waves as well as detect an ultrasonic echo. The ultrasound transducer preferably measures the regurgitation with the Doppler-effect . The ultra- sound transducer generates an ultrasound beam or pulse. The beam or pulse interacts with the regurgitation and is reflected to the ultrasound transducer, where the pulse or beam is detected. Alternatively an ultrasonic transmission measurement, which uses transit times of the ultrasound waves to calculate an average flow velocity, can be utilized.
In one embodiment the sensor may comprise a magnetic flow meter. The magnetic flow meter such as a Hall effect sensor measures the regurgitation with a potential across a cross-section of the valve. A magnetic field, e.g. an alternating magnetic field, may be generated electromagnetically by the annuloplasty system. The magnetic fields may be generated by a solenoid part of the annu¬ loplasty ring or part of the catheter. In case the solenoid is part of the annuloplasty ring, the sole¬ noid may be wound around the ring or is arranged in the annulo¬ plasty ring. An electric current is applied to the solenoid through the connector. This AC or DC current induces an oscil¬ lating or constant magnetic field. Regurgitated blood acts as moving electrical conductor and interacts with the magnetic field. Thus, an electromotive force is generated which may be detected with electrodes. The electrodes send a signal contain¬ ing information on the regurgitation to the connector and to the monitor .
In case the solenoid is part of the catheter, the solenoid may be wound around the catheter having a kind of C-shaped tip to have the solenoid partly around the annulus . Alternatively, the solenoid is arranged in the catheter in a C-form in a C-shaped tip .
Alternatively the magnetic field may be generated with permanent magnets comprised by the annuloplasty system, i.e. the annulo- plasty ring or the catheter. The magnetic field is applied basi¬ cally perpendicular to the blood flow.
The blood flow acts as a moving electrical conductor, which in- teracts with the magnetic field. As a result an electromotive force is induced. The induced electromotive force is related to the regurgitation. Said electromotive force is measured across a direction essentially perpendicular to the flow direction of the blood and essentially perpendicular to the magnetic field.
Alternatively, the change of the signal generated by the sole¬ noid and the regurgitation may be measured with any of the elec¬ trical parameters (tension, current or resistance) . Another in¬ direct alternative may be a measurement of the variations of the magnetic field.
Alternatively, said sensor comprises a light conductor, e.g. an optical fiber. The light conductor guides light, e.g. monochro¬ matic light, to the place where regurgitation is expected. The light interacts with the regurgitation and is reflected or scat¬ tered back to the light conductor/sensor. Alternatively, a sec¬ ond light conductor is utilized to detect the scattering.
The light is reflected or scattered back in a specific way if regurgitation is present. On the basis of this reflected or scattered back light, the sensor is able to detect if regurgita¬ tion is present. A detection of the regurgitation with light offers a fast measurement of the regurgitation. Additionally, the light conductor may allow a space saving design of the sensor. According to a further alternative embodiment a micro camera might be applied on the ring or a catheter. Also, instead of us¬ ing an optical fibre for transmission of light a fibre could be used for imaging using a camera outside of the body.
Preferably, the sensor comprises means to measure a spatial dis¬ tribution of a flow velocity. Preferably the spatial resolution is measured by a ID phased array of ultrasound transducers and/or by sweeping the ultrasound transducer through a series of positions. The spatial resolution allows a localization of the "leaks" in the valve.
Therewith, the manipulation procedure of the annuloplasty ring assembly can be adapted to reshape the mitral valve accordingly. Particularly, reshaping of the annuloplasty ring assembly in distinct places that are determined with the spatial distribu¬ tion the flow velocities is advantageous. Preferably, the sensor is connected to or connectable to or is part of the annuloplasty ring assembly. The sensor is preferably situated at a location suited for measuring the regurgitation. The sensor may be permanently connected to the annuloplasty ring assembly. A permanent connection would allow a long term moni- toring of the functioning of the valve.
Alternatively the sensor may be introduced after an implantation of the annuloplasty ring assembly for use during manipulation and/or removed after a manipulation procedure of the ring assem- bly. Thereby, the complexity of the annuloplasty ring assembly is reduced. Preferably, the annuloplasty system comprises a delivery device connected or connectable to said interface, wherein the delivery device is adapted to deliver said manipulator. The delivery device, e.g. a catheter, is preferably adapted to enter the annuloplasty assembly. Within the assembly the cathe¬ ter is connectable to the interface where the interface is ma¬ nipulated with heat or mechanical pressure or electrically or magnetically .
A "catheter" as used herein is intended refer to any flexible tubular structure suitable for medical applications adapted to provide a physical connection between the outside of the pa¬ tient's body and the annuloplasty ring assembly.
Alternative delivery devices may include but are not limited to tweezers or guide wires.
The delivery device is preferably removable and preferably adapted to reshape the annuloplasty assembly. This allows a sim¬ ple and versatile annuloplasty ring assembly.
Preferably, the delivery device has a signal connector, which can connect said sensor to the external monitor. Through the connector the information read out by the sensor becomes availa¬ ble to the external monitor. The connector may connect to the monitor with a wire or wirelessly.
Preferably, the system comprises a mechanical connector, prefer- ably on a common unit with the signal connector. Such a mechanical connector establishes a connection between the manipulator and the user. The delivery device is preferably introduced through the mechanical connector. Alternatively, the connector can be utilized to actuate the de¬ livery device, which may be comprised within the mechanical con¬ nector .
In one embodiment the delivery device includes the sensor. The sensor may be placed flexibly and repositioned if advantageous because the delivery device can be positioned as desired. An ad¬ ditional advantage is that the delivery device comprises the tools to manipulate the annuloplasty as well as the tools to as¬ sess the success of the manipulation in one device.
Alternatively, the delivery device as well as the annuloplasty ring assembly each includes at least one sensor. In such a setup at least one sensor could act as a sender and at least one sen¬ sor could act as a receiver.
Preferably, the manipulator includes the sensor. Preferably, the manipulator comprises an inflatable balloon. Preferred embodiments of the manipulator and delivery device comprising the inflatable balloon and the sensor are described in US 2014/0180126 Al, which is incorporated herein by refer¬ ence. Inflatable balloons comprised by a catheter are simple and versatile manipulators.
The sensor may be placed directly on the balloon. Alternatively, the sensor may be positioned on a tip of a balloon or on the connecting line used to inflate the balloon. The tip of the bal- loon may be separate part, comprised by the connecting line or may be part of the balloon. A placement of the sensor on the tip or the catheter has the advantage that it does not expose the sensor to the expansion of the balloon. Preferably the annuloplasty system comprises a closed loop con¬ trol system adapted to monitor the change in regurgitation and adapted to manipulate the adjustable ring in dependence of the monitored changes. In the closed loop control system the regur- gitation is measured and compared to a threshold. The control system controls the manipulator. The manipulator manipulates the annuloplasty ring assembly such that a difference between the measured regurgitation and the threshold is minimal. The control system automatically manipulates the assembly and thus a user interaction is minimal.
The invention further relates to a method of monitoring the ef¬ fectiveness of an annuloplasty treatment. In the method an annu¬ loplasty system is provided. The annuloplasty system comprises an annuloplasty ring assembly, at least one sensor and an exter¬ nal monitor or prompting device. The sensor is configured to de¬ tect regurgitation. The external monitor or the prompting device is configured to display information based on the regurgitation detected by the sensor. The annuloplasty ring assembly is manip- ulated with the manipulator. The regurgitation is detected with said sensor and information based on said detected regurgitation with said monitor or prompting device is provided. If said de¬ tected regurgitation is above a threshold the adjustment is re¬ peated. If regurgitation is below the threshold the manipulation is stopped. Therewith the manipulation is directly controlled and only performed in an adequate quantity.
Non-limiting embodiments of the invention are described, by way of example only, with respect to the accompanying drawings, in which:
Fig. 1: is a schematic view of a mitral valve with regurgita¬ tion and an annuloplasty ring assembly, Fig. 2: is a schematic view of a first embodiment of an annulo plasty system according to the invention,
Fig. 3: is a schematic view of a second embodiment of an annu- loplasty system according to the invention,
Fig. 4: is a schematic view of a third embodiment of an annulo plasty system according to the invention,
Fig. 5 is a schematic view of a fourth embodiment of an annu- loplasty system according to the invention,
Fig. 6: is a schematic view of a connector according to the in vention,
Fig. 7: is a schematic representation of an output of an exter nal monitor.
Figure 1 shows a cross-section schematic view of a mitral valve 14 with regurgitation 13 and an annuloplasty ring assembly 2. The annuloplasty ring assembly 2 is used to manipulate the mi¬ tral valve 14. The mitral valve 14 regulates a blood flow from an atrium 17 to a ventricle 18. Thereby a functioning mitral valve 14 allows only a flow from the atrium 17 to the ventricle
18. During systole when the pressure in the ventricle 18 is higher than in the atrium 17, the mitral valve 14 closes. The mitral valve 14 closes with an anterior leaflet 19 and a poste¬ rior leaflet 20. The leaflets 19, 20 coapt and therewith prohib¬ it a flow from the ventricle 18 to the atrium 17. The leaflets
19, 20 are held by tendinous chords 15, which hold the leaflets on the ventricular side. Certain medical conditions cause the leaflets 19, 20 to coapt insufficiently causing a regurgitation 13. The regurgitation 13 is a back flow of blood from the ventricle 18 through the mitral valve. In order to re-establish proper mitral valve functioning, the annuloplasty ring assembly 2 reshapes the mitral valve 14. Thereby, the coaptation of the leaflets 19, 20 is improved the regurgitation 13 reduced or stopped.
Figure 2 shows a schematic view of a first embodiment of an an- nuloplasty system 1. In this embodiment a sensor 8 is part of an annuloplasty ring assembly 2. The sensor 8 is connected with the external monitor 5 via connection means 21, a connector 12 and the transmission line 27.
The annuloplasty ring assembly 2 is arranged as an annular ring with an oval shape which is formed by a tube 9 with a "D" shaped or circular cross section. For a better understanding of the tube 9, the upper half of the tube 9 directed to the viewer is shown transparently. The tube 9 is made out of Nitinol. An outer wall 23 of the tube 9 is thicker than an inner wall 22 of the tube 9. Through this increased thickness of the outer wall 23 compared to the inner wall 22, the outer wall 23 is more rigid than the inner wall 22. Thereby the inner wall forms an inter¬ face through which the annuloplasty ring assembly may be manipu¬ lated. Especially the annuloplasty ring assemblies from
PCT/EP2013/072378 and PCT/EP2015/051782 are suitable.
The sensor 8 comprises an ultrasound transducer and measures the regurgitation 13 of the mitral valve 14. The ultrasound trans- ducer sends a pulse in the direction of the back flow. The back flow modifies the pulse. A reflection 11, which compromises information related to the regurgitation, is sent back to the sensor 8 via a transmission line 27. The transmission line 27 may transmit particularly optical signals, electrical signals and/or pressure. The sensor 8 detects the reflection and deduces the information related to the regurgitation. A signal of the sensor 8 is transmitted to the connector 12 over connecting means 21. From the connector 12 the signal is sent with the transmission line 27 to the external monitor 5. The external monitor 5 then displays the regurgita- tion 13 to a user.
A catheter 7 is introduced into the tube 9 through the connector 12. The catheter is then arranged between the outer wall 23 and the inner wall 22. The catheter 7 comprises an inflatable bal- loon 4. The balloon 4 is moveable around the circumference of the tube 9 (indicated with an arrow) .
The balloon 4 is expandable with gas or a liquid. The gas or liquid is provided by an actuator 20 over a connecting line 26. When inflated with gas, the balloon 4 expands and displaces the inner wall 22 inwardly towards an inside area 25 of the tube 9. Through the displacement of the inner wall 22, the mitral valve 14, to which the assembly 2 is applied, is adjusted. Due to the plastic deformation of the tube, the inwardly displaced wall re- mains in its expanded position. Ideally this manipulation of the assembly 2 causes a change in the coaptation 16 of the mitral valve leaflets 19, 20 (see Fig.l) and consequently a change in regurgitation. A new regurgitation 13' (see Fig. 7) is measured by the sensor 8 and compared to a previous regurgitation 13 and to a predefined threshold 35 (see fig. 7) . The new regurgitation 13' and the change in regurgitation are displayed on the exter¬ nal monitor. In case the regurgitation has not decreased below the predefined threshold, a user may decide now whether she wants to inflate the balloon 4 further. Alternatively the user may deflate the balloon 4 and move the balloon 4 to another place, where the balloon 4 may be inflated again. The inner wall 22 may therewith be displaced at multiple parts. At each dis- placement the success of the manipulation is monitored with the external monitor 5. Once the regurgitation decreases below the predefined threshold 35 (see fig. 7), the balloon 4 is removed from the tube 9. Figure 3 shows a schematic view of a second embodiment of the adjustable annuloplasty system 1. In the second embodiment the sensor 8 is comprised by the catheter 7. The catheter 7 is introduced into the tube 9 through a connector 12 and moveable around the circumference of the annuloplasty ring assembly 2 (indicated with an arrow) . The sensor 8 comprises an optical fi¬ ber and measures the regurgitation 13 of the mitral valve 14. The optical fiber emits the optical signal at an end of the op¬ tical fiber, in the direction of the back flow. The optical sig¬ nal is reflected by the blood, e.g. red blood cells.
An optical reflection 11, which compromises information related to the regurgitation, is sent back to the sensor 8. The sensor 8 detects the reflection and deduces the information related to the regurgitation. A signal of the sensor 8 is transmitted with the transmission line 27 to the external monitor 5. The external monitor 5 may process signal further. The external monitor 5 then displays the regurgitation 13 to a user. The user can then choose to manipulate the annuloplasty ring assembly with a bal¬ loon 4 (see Fig . 1 ) .
The annuloplasty ring assembly is adjustable with a different mechanism in this embodiment. Three actuation elements 10a, b, c are arranged in the tube 9 between the inner wall 22 and the outer wall 23. Two actuation elements 10a, b are arranged at lateral portions of the tube 9, one actuation element 10c is ar¬ ranged at a posterior portion of the tube 2. The three actuation elements 10 each comprise a stent. The stents have a section in- tegrally formed with the outer wall 23. The stents are expanda¬ ble with a balloon 4 (see Fig. 2) . The three stents may be ex¬ panded with the same balloon or with a separate balloon each. The balloon is inflated via the connecting line 26 (see Fig. 2) . The stents expand inwardly because of the part integrally formed with the outer wall 23 is more rigid than the rest of the stent. The stents therefore displace the inner wall 22 inwardly and ad¬ just the mitral valve leaflets 19, 20. The adjustment mechanism of the assembly 2 can be utilized independent of the positioning of the sensor 8. For example the actuation elements lOa-c in figure 3 may be utilized in the embodiments shown in figure 2 and 4.
Figure 4 shows a schematic view of a third embodiment of an an¬ nuloplasty system 1. In this embodiment the sensor 8 is com- prised by the balloon 4. The sensor 8 comprises an ultrasound transducer and measures the regurgitation 13 of the mitral valve 14. The ultrasound transducer sends a pulse in the direction of the back flow. The back flow modifies the pulse. A reflection 11, which compromises information related to the regurgitation, is sent back to the sensor 8. The sensor 8 detects the reflec¬ tion and deduces the information related to the regurgitation. A signal of the sensor 8 is transmitted with the transmission line 27 to the external monitor 5. The external monitor 5 may process signal further. The external monitor 5 then displays the regur- gitation 13 to a user. The user can modify the annuloplasty ring assembly 2 directly thereafter with the balloon 4.
Of course, any kind of sensor as disclosed herein might be part of any element of the annuloplasty system as described herein. Hence, the balloon might e.g. comprise an optical sensor or the catheter an ultrasound transducer etc.
Figure 5 shows a schematic view of a fourth embodiment of an an- nuloplasty system according to the invention. In this embodiment a solenoid 39 is wound around the tube 9. The tube according to Figure 5 is an open ring such. An electric current is applied to the solenoid 39 through connector 12. This AC or DC current in¬ duces an oscillating or constant magnetic field 40. A regurgita- tion 13, e.g. a regurgitation of blood, acts as moving electrical conductor and interacts with the magnetic field 40. Thus, an electromotive force is generated which may be detected with electrodes 38. The electrodes 38 send a signal containing infor¬ mation on the regurgitation 13 to the connector 12.
Figure 6 shows a schematic view of the connector 12. The con¬ nector comprises two parts: a signal connector 36 and a mechani¬ cal connector 37. The signal connector 36 is connected to the sensor with a sensor connection port 29 and to the external mon- itor with a monitor connection port 30. The mechanical connector 37 establishes an operative connection between an actuator connection port 28 and a manipulator connection port 38. Both connection ports 38 and 29 may be connectable or connected or part of to the connecting line 26.
Figure 7 shows a schematic representation of an output of an ex¬ ternal monitor 5. The external monitor 5 displays a flow veloci¬ ty on the y axis 32 and a time on the x-axis 31. The flow veloc¬ ity may be measured at a particular location or an average ve- locity over the cross-section of the valve. Preferably, the flow velocity at the position of the regurgitation is displayed. A positive flow 33 represents the blood flowing in the intended direction. A negative flow represents the regurgitation 13. An integration over the negative flow may indicate the volume 34 of blood that flows back. The user would identify the regurgitation 13 on the monitor. Then the user would manipulate the annulo- plasty ring assembly 2 (see fig. 2) . Ideally the manipulation would improve the coaptation 16 (see fig. 2) and thus the regur¬ gitation 13 and the volume 34 would decrease. The user would continue to manipulate until the regurgitation 34 drops below a threshold 35. Alternatively or additionally a threshold for the volume could be displayed.

Claims

Claims
1. An annuloplasty system (1) comprising
an annuloplasty ring assembly (2) having an interface (9) adapted to establish an operative connection with a manipula¬ tor (4) for manipulating said annuloplasty ring assembly (2), at least one sensor (8) configured to detect a regurgitation (13) of a valve and
an external monitor (5) or prompting device adapted to provide information based on said detected regurgitation (13) .
2. The system (1) according to claim 1, wherein said sensor comprises a Doppler-effect sensor.
3. The system (1) according to claim 1 or 2, wherein said sensor comprises an ultrasound transducer (6) .
4. The system (1) according to claim 1, wherein said sensor comprises a magnetic flow meter.
5. The system (1) according to claim 1 or 2, wherein said sensor comprises a light conductor.
6. The system (1) according to claim 3, wherein the sensor com- prises means to measure a spatial distribution of the regurgi¬ tation (13) .
7. The system (1) according to one of the preceding claims,
wherein said sensor is connected to or connectable to or part of the annuloplasty ring assembly (2) .
8. The system (1) according to one of the preceding claims, further comprising a delivery device connected or connectable to said interface (9), wherein the delivery device (7) is adapted to deliver said manipulator (4) .
The system (1) according to claim 8, wherein the delivery device (7) has a connector, which can connect said sensor (8) to an external monitor (5) adapted to display said information based on said detected regurgitation (13).
The system (1) according to one of the preceding claims, comprising a mechanical connector, preferably on a common unit with the signal connector.
The system (1) according to one of the claims 8 to 10, wherein said delivery device (7) includes said sensor (8) .
The system (1) according to one of the 1 to 11, wherein said manipulator (4) includes said sensor (8) .
The system (1) according to one of the preceding claims, wherein said manipulator (4) comprises an inflatable balloon
Method of monitoring the effectiveness of an annuloplasty treatment comprising the steps of:
a) providing an annuloplasty system (1), preferably an an¬ nuloplasty system (1) according to one of the claims 1- 12, having an annuloplasty ring assembly (2) and at least one sensor (8) to detect regurgitation (13) and an external monitor (5) or prompting device to provide in¬ formation based on said detected regurgitation (13) b) manipulating the annuloplasty ring assembly (2) with the manipulator (4),
c) detecting regurgitation (13) with said sensor, d) providing information based on said detected regurgita¬ tion (13) with said monitor (5) or prompting device, e) if said detected regurgitation is above a threshold
starting again with step b) or if said detected regurgi- tation is below a threshold stopping manipulation of the ring assembly (2) .
PCT/EP2016/059623 2015-04-29 2016-04-29 An annuloplasty system and a method for monitoring the effectiveness of an annuloplasty treatment WO2016174210A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP16719099.0A EP3288494B1 (en) 2015-04-29 2016-04-29 Annuloplasty system for monitoring the effectiveness of an annuloplasty treatment
US15/569,813 US11147670B2 (en) 2015-04-29 2016-04-29 Annuloplasty system and a method for monitoring the effectiveness of an annuloplasty treatment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15165726.9 2015-04-29
EP15165726.9A EP3087952A1 (en) 2015-04-29 2015-04-29 An annuloplasty system and a method for monitoring the effectiveness of an annuloplasty treatment

Publications (1)

Publication Number Publication Date
WO2016174210A1 true WO2016174210A1 (en) 2016-11-03

Family

ID=53015669

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2016/059623 WO2016174210A1 (en) 2015-04-29 2016-04-29 An annuloplasty system and a method for monitoring the effectiveness of an annuloplasty treatment

Country Status (3)

Country Link
US (1) US11147670B2 (en)
EP (2) EP3087952A1 (en)
WO (1) WO2016174210A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019015747A1 (en) 2017-07-18 2019-01-24 Kephalios S.A.S. Adjustable percutaneous annuloplasty devices, delivery systems, a method for percutaneously deploying an annuloplasty device and a method performed by one or more processing devices

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8608797B2 (en) 2005-03-17 2013-12-17 Valtech Cardio Ltd. Mitral valve treatment techniques
US11660190B2 (en) 2007-03-13 2023-05-30 Edwards Lifesciences Corporation Tissue anchors, systems and methods, and devices
US8382829B1 (en) 2008-03-10 2013-02-26 Mitralign, Inc. Method to reduce mitral regurgitation by cinching the commissure of the mitral valve
US8715342B2 (en) 2009-05-07 2014-05-06 Valtech Cardio, Ltd. Annuloplasty ring with intra-ring anchoring
US10517719B2 (en) 2008-12-22 2019-12-31 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US8911494B2 (en) 2009-05-04 2014-12-16 Valtech Cardio, Ltd. Deployment techniques for annuloplasty ring
US9180007B2 (en) 2009-10-29 2015-11-10 Valtech Cardio, Ltd. Apparatus and method for guide-wire based advancement of an adjustable implant
WO2011067770A1 (en) 2009-12-02 2011-06-09 Valtech Cardio, Ltd. Delivery tool for implantation of spool assembly coupled to a helical anchor
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
EP3656434B1 (en) 2011-11-08 2021-10-20 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
JP6153938B2 (en) 2011-12-12 2017-06-28 デイヴィッド・アロン Heart valve repair device
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
WO2014064694A2 (en) 2012-10-23 2014-05-01 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
WO2014087402A1 (en) 2012-12-06 2014-06-12 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of a tool
US9724084B2 (en) 2013-02-26 2017-08-08 Mitralign, Inc. Devices and methods for percutaneous tricuspid valve repair
US10449333B2 (en) 2013-03-14 2019-10-22 Valtech Cardio, Ltd. Guidewire feeder
CN105283214B (en) 2013-03-15 2018-10-16 北京泰德制药股份有限公司 Translate conduit, system and its application method
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US10070857B2 (en) 2013-08-31 2018-09-11 Mitralign, Inc. Devices and methods for locating and implanting tissue anchors at mitral valve commissure
US10299793B2 (en) 2013-10-23 2019-05-28 Valtech Cardio, Ltd. Anchor magazine
EP3397207A4 (en) 2015-12-30 2019-09-11 Mitralign, Inc. System and method for reducing tricuspid regurgitation
US10751182B2 (en) 2015-12-30 2020-08-25 Edwards Lifesciences Corporation System and method for reshaping right heart
CN113633435A (en) 2016-01-29 2021-11-12 内奥瓦斯克迪亚拉公司 Prosthetic valve for preventing outflow obstruction
US10702274B2 (en) 2016-05-26 2020-07-07 Edwards Lifesciences Corporation Method and system for closing left atrial appendage
CN113893064A (en) 2016-11-21 2022-01-07 内奥瓦斯克迪亚拉公司 Methods and systems for rapid retrieval of transcatheter heart valve delivery systems
WO2018159708A1 (en) * 2017-02-28 2018-09-07 富士フイルム株式会社 Blood flow analyzing device and method, and program
US11045627B2 (en) 2017-04-18 2021-06-29 Edwards Lifesciences Corporation Catheter system with linear actuation control mechanism
CA3073834A1 (en) 2017-08-25 2019-02-28 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US10835221B2 (en) 2017-11-02 2020-11-17 Valtech Cardio, Ltd. Implant-cinching devices and systems
US10980635B2 (en) * 2018-01-07 2021-04-20 William Joseph Drasler Annuloplasty device and methods
CA3086884A1 (en) 2018-01-24 2019-08-01 Valtech Cardio, Ltd. Contraction of an annuloplasty structure
EP3743014B1 (en) 2018-01-26 2023-07-19 Edwards Lifesciences Innovation (Israel) Ltd. Techniques for facilitating heart valve tethering and chord replacement
CN112384175A (en) 2018-07-12 2021-02-19 瓦尔泰克卡迪欧有限公司 Annuloplasty system and locking tool therefor
AU2019374743B2 (en) 2018-11-08 2022-03-03 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
US11602429B2 (en) 2019-04-01 2023-03-14 Neovasc Tiara Inc. Controllably deployable prosthetic valve
WO2020210652A1 (en) 2019-04-10 2020-10-15 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
CA3140925A1 (en) 2019-05-20 2020-11-26 Neovasc Tiara Inc. Introducer with hemostasis mechanism
AU2020295566B2 (en) 2019-06-20 2023-07-20 Neovasc Tiara Inc. Low profile prosthetic mitral valve
BR112021026675A2 (en) 2019-10-29 2022-07-19 Edwards Lifesciences Innovation Israel Ltd TISSUE ANCHOR AND ANNULOPLASTY TECHNOLOGIES

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6398734B1 (en) * 1997-10-14 2002-06-04 Vascusense, Inc. Ultrasonic sensors for monitoring the condition of flow through a cardiac valve
US6406493B1 (en) 2000-06-02 2002-06-18 Hosheng Tu Expandable annuloplasty ring and methods of use
WO2006012013A2 (en) 2004-06-29 2006-02-02 Micardia Corporation Adjustable cardiac valve implant with selective dimensional adjustment
US20080027483A1 (en) * 2002-08-29 2008-01-31 Mitralsoluations, Inc. Implantable devices for controlling the size and shape of an anatomical structure or lumen
US20110301699A1 (en) * 1999-06-25 2011-12-08 Hansen Medical, Inc. Apparatus and methods for treating tissue
US20120123284A1 (en) * 2010-11-17 2012-05-17 Arash Kheradvar Wireless hemodynamic monitoring system integrated with implantable heart valves
EP2468215A1 (en) 2010-12-22 2012-06-27 Centre Hospitaller Universitaire Vaudois (CHUV) Annuloplasty ring
US20130006352A1 (en) 2011-06-29 2013-01-03 Mitralix Ltd. Heart valve repair devices and methods
US20140180126A1 (en) 2012-12-20 2014-06-26 Volcano Corporation Catheter with balloon and imaging
WO2015058808A1 (en) * 2013-10-25 2015-04-30 Kephalios S.A.S. Adjustable annuloplasty ring and system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10327743B2 (en) 1999-04-09 2019-06-25 Evalve, Inc. Device and methods for endoscopic annuloplasty
EP1646332B1 (en) * 2003-07-18 2015-06-17 Edwards Lifesciences AG Remotely activated mitral annuloplasty system
WO2005107862A1 (en) 2004-04-30 2005-11-17 Flea Street Translational, Llc Methods and devices for modulation of heart valve function
US20070142907A1 (en) 2005-12-16 2007-06-21 Micardia Corporation Adjustable prosthetic valve implant
US20070276478A1 (en) 2006-05-12 2007-11-29 Micardia Corporation Intraoperative and post-operative adjustment of an annuloplasty ring
EP2904989A1 (en) 2014-02-11 2015-08-12 Kephalios S.A.S. Adjustable annuloplasty device
CN106456043B (en) 2014-04-16 2019-12-31 博洛尼亚大学 Heart valve prosthesis with integrated electronic circuit for measuring intra-valve electrical impedance and system for monitoring prosthesis function
EP3182932B1 (en) * 2014-08-18 2019-05-15 St. Jude Medical, Cardiology Division, Inc. Annuloplasty ring with sensor
US10433791B2 (en) * 2014-08-18 2019-10-08 St. Jude Medical, Cardiology Division, Inc. Prosthetic heart devices having diagnostic capabilities
CA2998709A1 (en) * 2014-09-17 2016-03-24 Canary Medical Inc. Devices, systems and methods for using and monitoring medical devices

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6398734B1 (en) * 1997-10-14 2002-06-04 Vascusense, Inc. Ultrasonic sensors for monitoring the condition of flow through a cardiac valve
US20110301699A1 (en) * 1999-06-25 2011-12-08 Hansen Medical, Inc. Apparatus and methods for treating tissue
US6406493B1 (en) 2000-06-02 2002-06-18 Hosheng Tu Expandable annuloplasty ring and methods of use
US20080027483A1 (en) * 2002-08-29 2008-01-31 Mitralsoluations, Inc. Implantable devices for controlling the size and shape of an anatomical structure or lumen
WO2006012013A2 (en) 2004-06-29 2006-02-02 Micardia Corporation Adjustable cardiac valve implant with selective dimensional adjustment
US20120123284A1 (en) * 2010-11-17 2012-05-17 Arash Kheradvar Wireless hemodynamic monitoring system integrated with implantable heart valves
EP2468215A1 (en) 2010-12-22 2012-06-27 Centre Hospitaller Universitaire Vaudois (CHUV) Annuloplasty ring
US20130006352A1 (en) 2011-06-29 2013-01-03 Mitralix Ltd. Heart valve repair devices and methods
US20140180126A1 (en) 2012-12-20 2014-06-26 Volcano Corporation Catheter with balloon and imaging
WO2015058808A1 (en) * 2013-10-25 2015-04-30 Kephalios S.A.S. Adjustable annuloplasty ring and system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019015747A1 (en) 2017-07-18 2019-01-24 Kephalios S.A.S. Adjustable percutaneous annuloplasty devices, delivery systems, a method for percutaneously deploying an annuloplasty device and a method performed by one or more processing devices

Also Published As

Publication number Publication date
EP3288494B1 (en) 2021-09-22
EP3288494A1 (en) 2018-03-07
US11147670B2 (en) 2021-10-19
US20180140420A1 (en) 2018-05-24
EP3087952A1 (en) 2016-11-02

Similar Documents

Publication Publication Date Title
US11147670B2 (en) Annuloplasty system and a method for monitoring the effectiveness of an annuloplasty treatment
JP5580319B2 (en) Improved artificial valve
CA2913060C (en) Cardiac function evaluation system
US6398734B1 (en) Ultrasonic sensors for monitoring the condition of flow through a cardiac valve
US20180035971A1 (en) System And Method For Non-Invasive Measurement Of Pressure Inside A Body Including Intravascular Blood Pressure
CN107660137A (en) Method and apparatus for treating valvular heart disease
WO2014210299A1 (en) Device, system, and method for implanting a prosthetic heart valve
AU5338698A (en) Pressure-sensing stent
US8172900B2 (en) Microsensor system for application in biomechanics
JP2011509099A (en) Device for treating aneurysms
JP2005185644A5 (en)
CN105324094A (en) Systems and methods for intra-operative eye biometry or refractive measurement
JP2020506010A (en) Implantable force gauge
CN112739271A (en) Apparatus and system for increasing visibility of an object
WO2018183949A1 (en) Magnetically actuatable probe for tissue penetration
WO2015013536A2 (en) Heart valve sizing
US10905465B2 (en) Delivery devices and wall apposition sensing
WO1997047232A1 (en) Tonometer air pulse generator
JP2004290462A (en) Optimal position profiling system of applicator
CN107440820B (en) Device for monitoring the positioning of a prosthetic heart valve and corresponding method
US20240024037A1 (en) Systems and methods of generating reconstructed images for interventional medical procedures
CN105828724A (en) System and instrument for delivering an object and method for detecting delivery
WO2022003682A1 (en) Intraocular manipulation device
EP4026499A1 (en) System and method for determining position information
Ohta et al. Nonsymmetric Leaflet Motion of St. Jude Medical Mitral Valves Simulated with a Computer‐Controlled Hydraulic Mock Circulator

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16719099

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2016719099

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 15569813

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE